GMO ‘steak chips’: Replacing slaughterhouses with genetically engineered meat

lab made beef burger mark post x

MIT Technology Review checks in with Modern Meadow CEO and cofounder Andras Forgacs.

Modern Meadow aims to create leather and meat products brewed in cell-culture vats rather than from slaughtering animals. This has the potential for greatly reducing the environmental impacts of meat and leather production.

What’s the idea behind Modern Meadow?

The company was founded to expand the ideas from biomedical tissue engineering: if we can grow skin, can we make leather? If we can grow muscle, can we make meat? We’ve now done so—and are working with chefs and leather artisans to perfect our materials. We’re a materials company, and our near-term focus is on leather. You want to make sure we have high quality and have achieved the right kind of material, and then develop a process that can scale.

But you’ve also been making batches of snacks you are calling “steak chips” made from cow muscle cells, with flavors like teriyaki and shiitake mushroom. You didn’t bring any. When will they be ready?

We’re doing private tastings but are still are refining the recipe and developing ways to scale production. We have to think about whether this is the project we take to market. We hope steak chips will be available commercially within five years, and eventually competitive with high-end snack foods like kale chips, but it depends on regulatory process and scaling the manufacturing. We’ve been told they taste a little like beef jerky, but crunchy.

Read full original article: EmTech: Three Questions with the Man Who Grows Meat

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot 2026-05-06 at 2.19
Vaccine shootout at the CDC 
ChatGPT-Image-May-6-2026-03_41_05-PM
‘Protecting the integrity of science’: Kennedy’s FDA blocks release of taxpayer-funded studies finding COVID and shingles vaccines safe
What explains Homo sapiens’ huge brains? Ancient climate change played a role
Viewpoint: Internal White House documents detail administration’s strategy to undermine climate science
ChatGPT-Image-May-7-2026-11_28_04-AM-2
‘Conflict entrepreneurs’ are driving disinformation and shaping public opinion
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of how  the White House embraced the fringe claim that scientists are being mysteriously murdered
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.